Isthmus Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.7M Buy
149,401
+1,166
+0.8% +$106K 1.22% 29
2026
Q2
$13.6M Buy
148,235
+2,615
+2% +$229K 1.31% 27
2026
Q1
$12.4M Buy
145,620
+5,273
+4% +$470K 1.3% 31
2025
Q4
$11.1M Buy
140,347
+932
+0.7% +$73.1K 1.23% 32
2025
Q3
$11.1K Buy
139,415
+1,996
+1% +$170K ﹤0.01% 139
2025
Q2
$12.5M Buy
137,419
+308
+0.2% +$28.1K 1.46% 29
2025
Q1
$12.8M Buy
137,111
+2,354
+2% +$211K 1.61% 21
2024
Q4
$12.3M Sell
134,757
-197
-0.1% -$18.8K 1.49% 26
2024
Q3
$14M Sell
134,954
-1,063
-0.8% -$108K 1.66% 22
2024
Q2
$13.2M Sell
136,017
-1,367
-1% -$126K 1.55% 16
2024
Q1
$12.4M Buy
137,384
+25
+0% +$2.12K 1.4% 28
2023
Q4
$10.9M Buy
137,359
+4,718
+4% +$355K 1.42% 33
2023
Q3
$9.43M Buy
132,641
+512
+0.4% +$38.3K 1.36% 33
2023
Q2
$10.2M Buy
132,129
+970
+0.7% +$75.1K 1.39% 32
2023
Q1
$9.9M Buy
131,159
+3,304
+3% +$246K 1.39% 31
2022
Q4
$10.1M Sell
127,855
-1,202
-0.9% -$90.1K 1.51% 23
2022
Q3
$9.07M Buy
129,057
+683
+0.5% +$53.6K 1.56% 21
2022
Q2
$10.3M Buy
128,374
+1,465
+1% +$115K 1.92% 14
2022
Q1
$9.6M Buy
126,909
+6,421
+5% +$509K 1.58% 30
2021
Q4
$10.3M Buy
120,488
+1,449
+1% +$113K 1.72% 21
2021
Q3
$9M Buy
119,039
+1,144
+1% +$90.8K 1.63% 24
2021
Q2
$9.6M Sell
117,895
-1,326
-1% -$108K 1.69% 21
2021
Q1
$9.4M Buy
+119,221
New +$9.34M 1.73% 23
2019
Q2
– Sell
-72,504
Closed -$1.27M – 150
2019
Q1
$1.27M Buy
+72,504
New +$4.68M 0.31% 61
2018
Q4
– Sell
-260
Closed -$17K – 161
2018
Q3
$17K Hold
260
– – ﹤0.01% 230
2018
Q2
$17K Hold
260
– – ﹤0.01% 218
2018
Q1
$19K Hold
260
– – 0.01% 212
2017
Q4
$20K Hold
260
– – 0.01% 209
2017
Q3
$19K Hold
260
– – 0.01% 214
2017
Q2
$19K Hold
260
– – 0.01% 223
2017
Q1
$19K Buy
+260
New +$18.2K 0.01% 223

Other funds holding CL

Isthmus Partners's CL Position: Q3 2026 in Review

Isthmus Partners increased its Colgate-Palmolive (CL) stake by 0.79% in Q3 2026, buying an estimated $106K and bringing the position to 149,401 shares worth $12.7M. The position accounts for 1.22% of the portfolio, ranked #29.

Isthmus Partners first reported a position in CL in Q1 2017 and has held it in 31 quarters since. The position peaked at $14M in Q3 2024. 1,967 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Isthmus Partners held 149,401 shares of Colgate-Palmolive worth $12.7M as of Q3 2026.
  • Isthmus Partners bought 1,166 Colgate-Palmolive shares in Q3 2026, an estimated $106K.
  • Colgate-Palmolive made up 1.22% of Isthmus Partners's portfolio in Q3 2026, its #29 holding.
  • Isthmus Partners first reported a position in Colgate-Palmolive in Q1 2017 and has held it in 31 quarters since.
  • Isthmus Partners's Colgate-Palmolive position peaked at $14M in Q3 2024.
  • 1,967 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Isthmus Partners's 13F filing for Q3 2026, filed 21 Oct 2026.